245 related articles for article (PubMed ID: 17951193)
21. Neuroendocrine carcinomas of the prostate and urinary bladder: a diagnostic and therapeutic challenge.
Helpap B; Klöppel G
Virchows Arch; 2002 Mar; 440(3):241-8. PubMed ID: 11889593
[TBL] [Abstract][Full Text] [Related]
22. Large cell neuroendocrine carcinoma with sarcomatous changes of the endometrium: a case report with immunohistochemical studies and molecular genetic study of KIT and PDGFRA.
Terada T
Pathol Res Pract; 2010 Jun; 206(6):420-5. PubMed ID: 20189318
[TBL] [Abstract][Full Text] [Related]
23. Primary mesenteric malignant mixed mesodermal (müllerian) tumor with neuroendocrine differentiation.
Cokelaere K; Michielsen P; De Vos R; Sciot R
Mod Pathol; 2001 May; 14(5):515-20. PubMed ID: 11353063
[TBL] [Abstract][Full Text] [Related]
24. [Analysis of clinicopathological features of intestinal neuroendocrine neoplasms].
Gao W; Liu SM; Lu HZ; Liang J; Yuan YL; Liu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):450-6. PubMed ID: 22967448
[TBL] [Abstract][Full Text] [Related]
25. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
[TBL] [Abstract][Full Text] [Related]
26. Small cell neuroendocrine carcinoma of the prostate: incidence and a report of four cases with an examination of KIT and PDGFRA.
Terada T
Prostate; 2012 Jul; 72(10):1150-6. PubMed ID: 22127977
[TBL] [Abstract][Full Text] [Related]
27. Urinary Large Cell Neuroendocrine Carcinoma: A Clinicopathologic Analysis of 22 Cases.
Wang G; Yuan R; Zhou C; Guo C; Villamil C; Hayes M; Eigl BJ; Black P
Am J Surg Pathol; 2021 Oct; 45(10):1399-1408. PubMed ID: 34074810
[TBL] [Abstract][Full Text] [Related]
28. Lipoid-cell variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of five cases.
Leroy X; Gonzalez S; Zini L; Aubert S
Am J Surg Pathol; 2007 May; 31(5):770-3. PubMed ID: 17460462
[TBL] [Abstract][Full Text] [Related]
29. Insights from a whole cystectomy specimen--association of primary small cell carcinoma of the bladder with transitional cell carcinoma in situ.
Gaisa NT; Tilki D; Losen I; Dahl E; Stoehr R; Stief CG; Knüchel R
Hum Pathol; 2008 Aug; 39(8):1258-62. PubMed ID: 18547617
[TBL] [Abstract][Full Text] [Related]
30. Primary small cell neuroendocrine carcinoma of the urinary bladder: a clinicopathologic, immunohistochemical, and ultrastructural evaluation.
Hussein MR; Al-Assiri M; Eid RA; Musalam AO
Ultrastruct Pathol; 2010 Aug; 34(4):232-5. PubMed ID: 20594044
[TBL] [Abstract][Full Text] [Related]
31. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma.
Sun L; Sakurai S; Sano T; Hironaka M; Kawashima O; Nakajima T
Pathol Int; 2009 Aug; 59(8):522-9. PubMed ID: 19627535
[TBL] [Abstract][Full Text] [Related]
32. Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases.
Yun JP; Zhang MF; Hou JH; Tian QH; Fu J; Liang XM; Wu QL; Rong TH
BMC Cancer; 2007 Mar; 7():38. PubMed ID: 17335582
[TBL] [Abstract][Full Text] [Related]
33. Combined large cell neuroendocrine and endometrioid carcinoma of the endometrium.
Mulvany NJ; Allen DG
Int J Gynecol Pathol; 2008 Jan; 27(1):49-57. PubMed ID: 18156975
[TBL] [Abstract][Full Text] [Related]
34. Primary large cell neuroendocrine carcinoma of the urinary bladder.
Lee KH; Ryu SB; Lee MC; Park CS; Juhng SW; Choi C
Pathol Int; 2006 Nov; 56(11):688-93. PubMed ID: 17040293
[TBL] [Abstract][Full Text] [Related]
35. Primary neuroendocrine carcinoma of the vagina with Merkel cell carcinoma phenotype.
Coleman NM; Smith-Zagone MJ; Tanyi J; Anderson ML; Coleman RL; Dyson SW; Reed JA
Am J Surg Pathol; 2006 Mar; 30(3):405-10. PubMed ID: 16538063
[TBL] [Abstract][Full Text] [Related]
36. How wide is the spectrum of neuroendocrine carcinoma of the urinary bladder?
Vakar-Lopez F; True LD
Am J Clin Pathol; 2007 Nov; 128(5):723-5. PubMed ID: 17951191
[No Abstract] [Full Text] [Related]
37. The value of immunohistochemical expression of TTF-1, CK7 and CK20 in the diagnosis of primary and secondary lung carcinomas.
Al-Zahrani IH
Saudi Med J; 2008 Jul; 29(7):957-61. PubMed ID: 18626520
[TBL] [Abstract][Full Text] [Related]
38. Distinction of high-grade neuroendocrine carcinoma/small cell carcinoma from conventional urothelial carcinoma of urinary bladder: an immunohistochemical approach.
Thompson S; Cioffi-Lavina M; Chapman-Fredricks J; Gomez-Fernandez C; Fernandez-Castro G; Jorda M
Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):395-9. PubMed ID: 21617524
[TBL] [Abstract][Full Text] [Related]
39. [Primary neuroendocrine carcinoma of the bladder: diagnosis and treatment].
Karmouni T; Rioux-Leclercq N; Bensalah K; Alva A; Patard JJ; Guillé F; Lobel B
Prog Urol; 2000 Sep; 10(4):590-4. PubMed ID: 11064903
[TBL] [Abstract][Full Text] [Related]
40. Thyroid transcription factor-1 and "basal marker"--expressing small cell carcinoma of the breast.
Ersahin C; Bandyopadhyay S; Bhargava R
Int J Surg Pathol; 2009 Oct; 17(5):368-72. PubMed ID: 19578049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
